Milena Kohn

839 total citations
9 papers, 81 citations indexed

About

Milena Kohn is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Milena Kohn has authored 9 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Milena Kohn's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and COVID-19 and healthcare impacts (2 papers). Milena Kohn is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and COVID-19 and healthcare impacts (2 papers). Milena Kohn collaborates with scholars based in France, Belgium and United Kingdom. Milena Kohn's co-authors include Philippe Rousselot, Camille Bigenwald, David Boutboul, Véronique Meignin, Thierry Lazure, Bettina Fabiani, L. Fardet, Olivier Lambotte, Éric Oksenhendler and Mathieu Uzzan and has published in prestigious journals such as Blood, British Journal of Haematology and Haematologica.

In The Last Decade

Milena Kohn

9 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milena Kohn France 5 42 31 26 19 14 9 81
Paibel Aguayo‐Hiraldo United States 8 23 0.5× 49 1.6× 45 1.7× 23 1.2× 11 0.8× 23 135
Colleen Timlin United States 5 49 1.2× 24 0.8× 22 0.8× 14 0.7× 7 0.5× 14 99
Giovanna Leone Italy 6 43 1.0× 41 1.3× 25 1.0× 6 0.3× 19 1.4× 14 106
Vesa Lindström Finland 8 30 0.7× 41 1.3× 23 0.9× 27 1.4× 26 1.9× 13 117
Malgorzata McMasters United States 7 59 1.4× 13 0.4× 35 1.3× 13 0.7× 17 1.2× 18 120
J. Allyson Hays United States 3 57 1.4× 36 1.2× 10 0.4× 28 1.5× 6 0.4× 4 82
Francesco Corrente Italy 5 15 0.4× 42 1.4× 28 1.1× 24 1.3× 15 1.1× 12 130
Eva Bubanská Slovakia 7 34 0.8× 28 0.9× 30 1.2× 21 1.1× 4 0.3× 13 110
Clémence Mediavilla France 8 88 2.1× 26 0.8× 31 1.2× 10 0.5× 31 2.2× 18 137
Laura Solán Spain 7 79 1.9× 43 1.4× 35 1.3× 9 0.5× 7 0.5× 21 110

Countries citing papers authored by Milena Kohn

Since Specialization
Citations

This map shows the geographic impact of Milena Kohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milena Kohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milena Kohn more than expected).

Fields of papers citing papers by Milena Kohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milena Kohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milena Kohn. The network helps show where Milena Kohn may publish in the future.

Co-authorship network of co-authors of Milena Kohn

This figure shows the co-authorship network connecting the top 25 collaborators of Milena Kohn. A scholar is included among the top collaborators of Milena Kohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milena Kohn. Milena Kohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Kohn, Milena, et al.. (2024). Could it be VEXAS?. Annals of Hematology. 103(6). 2169–2171. 3 indexed citations
3.
Visco, Carlo, Sandra Bašić‐Kinda, Olivier Hermine, et al.. (2022). Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry. HemaSphere. 6(5). e0711–e0711. 8 indexed citations
4.
Kohn, Milena, et al.. (2022). Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. Platelets. 33(4). 652–653. 4 indexed citations
6.
Kohn, Milena, Fatiha Merabet, Stéphanie Marque‐Juillet, et al.. (2021). A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients. Blood. 138(Supplement 1). 3751–3751. 1 indexed citations
7.
Andrieu, Guillaume P., Milena Kohn, Mathieu Simonin, et al.. (2021). PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL. Blood. 138(19). 1855–1869. 22 indexed citations
8.
Kohn, Milena, Alexandre Karras, Mohamad Zaidan, et al.. (2020). Lymphomas with kidney involvement: the French multicenter retrospective LyKID study. Leukemia & lymphoma. 61(4). 887–895. 6 indexed citations
9.
Bigenwald, Camille, L. Fardet, Paul Coppo, et al.. (2018). A comprehensive analysis of Lymphoma‐associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. British Journal of Haematology. 183(1). 68–75. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026